Literature DB >> 32372088

Gastric ischemic preconditioning may reduce the incidence and severity of anastomotic leakage after οesophagectomy: a systematic review and meta-analysis.

Adamantios Michalinos1, Stavros A Antoniou1,2, Dimitrios Ntourakis1, Dimitrios Schizas3, Konstantinos Ekmektzoglou4, Aris Angouridis5, Elizabeth O Johnson1.   

Abstract

Anastomotic leakage after esophagectomy is a severe and life-threatening complication. Gastric ischemic preconditioning is a strategy for the improvement of anastomotic healing. Aim of this systematic review and meta-analysis is to investigate the impact of gastric ischemic preconditioning on postoperative morbidity. A systematic literature search was performed to identify studies comparing patients undergoing gastric ischemic preconditioning before esophagectomy with nonpreconditioned patients. Meta-analysis was conducted for the overall incidence of anastomotic leakage, severe anastomotic leakage, anastomotic stricture, postoperative morbidity, and mortality. Mantel-Haenszel odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. Subgroup analyses were performed concerning preconditioning technique, the interval between preconditioning and surgery and the extent of preconditioning. Fifteen cohort studies were identified. Gastric preconditioning was associated with reduced overall incidence of anastomotic leakage (OR 0.73; 95% CI, 0.53-1.0; P = 0.050) and severe anastomotic leakage (OR 0.27; 95% CI, 0.14-0.50; P < 0.010), but not with anastomotic stricture (OR 1.18; 95% CI 0.38 to 3.66; P = 0.780), major postoperative morbidity (OR 1.03; 95% CI 0.45 to 2.36; P = 0.940) or mortality (OR 0.69; 95% CI 0.39 to 1,23; P = 0.210). Subgroup analyses did not identify any differences between embolization and ligation while increasing the interval between preconditioning and esophagectomy as well as the extent of preconditioning might be beneficial. Gastric ischemic preconditioning may be associated with a reduced incidence of overall and severe anastomotic leakage. Randomized studies are necessary to further evaluate its impact on leakage, refine the technique and define patient populations that will benefit the most.
© The Author(s) 2020. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  delay phenomenon; esophageal neoplasms; esophagectomy; ischemic preconditioning

Mesh:

Year:  2020        PMID: 32372088     DOI: 10.1093/dote/doaa010

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  4 in total

1.  Indocyanine green fluorescence in robot-assisted minimally invasive esophagectomy with intrathoracic anastomosis: a prospective study.

Authors:  E M de Groot; G M Kuiper; A van der Veen; L Fourie; L Goense; S van der Horst; J W van den Berg; R van Hillegersberg; J P Ruurda
Journal:  Updates Surg       Date:  2022-08-17

2.  The ISCON-trial protocol: laparoscopic ischemic conditioning prior to esophagectomy in patients with esophageal cancer and arterial calcifications.

Authors:  A van der Veen; L M Schiffmann; R van Hillegersberg; W Schröder; E M de Groot; I Bartella; P A de Jong; A S Borggreve; L A A Brosens; D Pinto Dos Santos; H Fuchs; J P Ruurda; C J Bruns
Journal:  BMC Cancer       Date:  2022-02-05       Impact factor: 4.430

Review 3.  Role of Radiology in the Preoperative Detection of Arterial Calcification and Celiac Trunk Stenosis and Its Association with Anastomotic Leakage Post Esophagectomy, an Up-to-Date Review of the Literature.

Authors:  Antonios Tzortzakakis; Georgios Kalarakis; Biying Huang; Eleni Terezaki; Emmanouil Koltsakis; Aristotelis Kechagias; Andrianos Tsekrekos; Ioannis Rouvelas
Journal:  Cancers (Basel)       Date:  2022-02-17       Impact factor: 6.639

4.  Remote Ischaemic Preconditioning in Intra-Abdominal Cancer Surgery (RIPCa): A Pilot Randomised Controlled Trial.

Authors:  Aikaterini Papadopoulou; Matthew Dickinson; Theophilus L Samuels; Christian Heiss; Julie Hunt; Lui Forni; Ben C Creagh-Brown
Journal:  J Clin Med       Date:  2022-03-23       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.